Genprex, Inc. (GNPX)
Data as of , from SEC Form 4 filings.
See up to 3 months of GNPX. The 7-day demo opens the 1M and 3M ranges and puts GNPX on your watchlist.
Start 7-day demoLatest GNPX insider trades
About Genprex, Inc. (GNPX)
The SEC lists Genprex, Inc. under CIK 0001595248, in pharmaceutical preparations. It is grouped with Health Care companies on this site. A registration statement was filed on 21 November 2025. No offering has priced.
GNPX Form 4 activity by transaction type, last 90 days
No Form 4 activity for GNPX in the last 90 days.
GNPX insider transactions (Form 4)
1110 Form 4 filings on record, the earliest from Dec 6, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Brent M. Longnecker - Director | Open-market sale | Common Stock | 8 footnote F1 | $1.23 | $10 | |
| Brent M. Longnecker - Director | Open-market sale | Common Stock | 10 footnote F1 | $1.23 | $12 | |
| ||||||
| Mark Stanley Berger - Officer | Tax withholding / forfeiture | Common Stock | 7,168 footnote F1 | $2.00 | $14K | |
| ||||||
| Ryan M. Confer - Officer | Tax withholding / forfeiture | Common Stock | 9,330 footnote F1 | $2.00 | $19K | |
| ||||||
| Mark Stanley Berger - Officer | Tax withholding / forfeiture | Common Stock | 4,500 | $0.23 | $1K | |
| Ryan M. Confer - Officer | Tax withholding / forfeiture | Common Stock | 5,775 | $0.23 | $1K | |
| Toscano Jose Antonio Moreno - Director | Grant or award | Common Stock | 4,750 | $0.00 | - | |
| William R. Wilson Jr. - Director | Grant or award | Common Stock | 4,750 | $0.00 | - | |
| Ryan M. Confer - Officer | Grant or award | Common Stock | 29,375 | $0.00 | - | |
| Mark Stanley Berger - Officer | Grant or award | Common Stock | 18,250 | $0.00 | - | |
| Brent M. Longnecker - Director | Grant or award | Common Stock | 4,750 | $0.00 | - | |
Stock trades in GNPX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
GNPX insider trading FAQ
What is the latest insider trade for GNPX?
Genprex, Inc. (GNPX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-15. The full record for GNPX runs to 10 Form 4 filings, the earliest from 2024-12-06. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying GNPX stock?
No insider purchases of GNPX were filed in the last 90 days.
How many insiders are selling GNPX stock?
No insider sales of GNPX were filed in the last 90 days. 2 sales are on record for this company.
Where can I see GNPX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects GNPX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brent M. Longnecker view on EDGAR
- - Mark Stanley Berger view on EDGAR
- - Ryan M. Confer view on EDGAR
- - Mark Stanley Berger view on EDGAR
- - Ryan M. Confer view on EDGAR
- - Toscano Jose Antonio Moreno view on EDGAR
- - William R. Wilson Jr. view on EDGAR
- - Ryan M. Confer view on EDGAR
- - Mark Stanley Berger view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where GNPX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow GNPX with a 7-day demo
- GNPX on your watchlist
- Every GNPX Form 4 filing on record
- Up to 3 months of GNPX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive